DR. KEITH VOSSEL – CONTROVERSIAL NEW ALZHEIMER’S DRUG 4 23 22

A CONTROVERSIAL NEW DRUG TO TREAT ALZHEIMER’S DISEASE WAS APPROVED BY THE FDA LAST YEAR BUT SOME DOCTORS REMAIN SKEPTICAL AS TO WHETHER IT ACTUALLY WORKS. JOINING US TO DISCUSS IS DR. KEITH VOSSEL, DIRECTOR OF THE MARY S. EASTON CENTER FOR ALZHEIMER’S DISEASE RESEARCH AT UCLA.